You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy
|
|---|---|
| Published in |
Molecular Cancer, March 2010
|
| DOI | 10.1186/1476-4598-9-69 |
| Pubmed ID | |
| Authors |
Richard F. Kefford, Philip R. Clingan, Benjamin Brady, Andrea Ballmer, Adele Morganti, Peter Hersey |
Mendeley readers
The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | 2% |
| Unknown | 48 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 9 | 18% |
| Student > Bachelor | 8 | 16% |
| Student > Ph. D. Student | 6 | 12% |
| Student > Master | 5 | 10% |
| Other | 5 | 10% |
| Other | 9 | 18% |
| Unknown | 7 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 31% |
| Agricultural and Biological Sciences | 5 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 8% |
| Biochemistry, Genetics and Molecular Biology | 4 | 8% |
| Physics and Astronomy | 2 | 4% |
| Other | 5 | 10% |
| Unknown | 14 | 29% |